Mammalian tub protein

The present invention relates to the identification of novel nucleic acid molecules and proteins encoded by such nucleic acid molecules or degenerate variants thereof, that participate in the control of mammalian body weight. The nucleic acid molecules of the present invention represent the genes corresponding to the mammalian tub gene, a gene that is involved in the regulation of body weight.

Skip to:  ·  Claims  ·  References Cited  · Patent History  ·  Patent History

Claims

1. An isolated polypeptide comprising:

(a) the amino acid sequence shown in SEQ ID NO:2;
(b) the amino acid sequence shown in SEQ ID NO:8;
(c) an amino acid sequence encoded by the nucleic acid insert of the clone contained in ATCC Deposit No. 69856;
(d) the amino acid sequence encoded by the nucleic acid insert of the clone contained in ATCC Deposit No. 97222;
(e) the amino acid sequence encoded by the nucleic acid insert of the clone contained in ATCC Deposit No. 97221;
(f) the amino acid sequence encoded by the nucleic acid insert of the clone contained in ATCC Deposit No. 69874;
(g) an amino acid sequence encoded by the nucleic acid insert of the clone contained in ATCC Deposit No. 69857;
(h) an amino acid sequence encoded by the nucleic acid insert of the clone contained in ATCC Deposit No. 69858; or
(i) an amino acid sequence encoded by the nucleic acid insert of the clone contained in ATCC Deposit No. 69859.

2. The isolated polypeptide of claim 1 wherein the polypeptide comprises the amino acid sequence shown in SEQ ID NO:2.

3. The isolated polypeptide of claim 1 wherein the polypeptide comprises the amino acid sequence shown in SEQ ID NO:8.

4. The isolated polypeptide of claim 1 wherein the polypeptide comprises the amino acid sequence encoded by the nucleic acid insert of the clone contained in ATCC Deposit No. 69856.

5. The isolated polypeptide of claim 1 wherein the polypeptide comprises the amino acid sequence encoded by the nucleic acid insert of the clone contained in ATCC Deposit No. 97222.

6. The isolated polypeptide of claim 1 wherein the polypeptide comprises the amino acid sequence encoded by the nucleic acid insert of the clone contained in ATCC Deposit No. 97221.

7. The isolated polypeptide of claim 1 wherein the polypeptide comprises the amino acid sequence encoded by the nucleic acid insert of the clone contained in ATCC Deposit No. 69874.

8. The isolated polypeptide of claim 1 wherein the polypeptide comprises an amino acid sequence encoded by the nucleic acid insert of the clone contained in ATCC Deposit No. 69857.

9. The isolated polypeptide of claim 1 wherein the polypeptide comprises an amino acid sequence encoded by the nucleic acid insert of the clone contained in ATCC Deposit No. 69858.

10. The isolated polypeptide of claim 1 wherein the polypeptide comprises an amino acid sequence encoded by the nucleic acid insert of the clone contained in ATCC Deposit No. 69859.

11. An isolated polypeptide comprising:

(a) amino acid residues 1-133 shown in SEQ ID NO:2;
(b) amino acid residues 190-505 shown in SEQ ID NO:2;
(c) amino acid residues 1-133 and 190-505 shown in SEQ ID NO:2;
(d) amino acid residues 1-133 shown in SEQ ID NO:8;
(e) amino acid residues 190-506 shown in SEQ ID NO:8; or
(f) amino acid residues 1-133 and 190-506 shown in SEQ ID NO:8.

12. The isolated polypeptide of claim 11 wherein the polypeptide comprises amino acid residues 1-133 shown in SEQ ID NO:2.

13. The isolated polypeptide of claim 11 wherein the polypeptide comprises amino acid residues 190-505 shown in SEQ ID NO:2.

14. The isolated polypeptide of claim 11 wherein the polypeptide comprises amino acid residues 1-133 and 190-505 shown in SEQ ID NO:2.

15. The isolated polypeptide of claim 11 wherein the polypeptide comprises amino acid residues 1-133 shown in SEQ ID No:8.

16. The isolated polypeptide of claim 11 wherein the polypeptide comprises amino acid residues 190-506 shown in SEQ ID NO:8.

17. The isolated polypeptide of claim 11 wherein the polypeptide comprises amino acid residues 1-133 and 190-506 shown in SEQ ID NO:8.

18. The isolated polypeptide of claim 14 wherein the isolated polypeptide comprises amino acid residue 133 shown in SEQ ID NO:2 attached via a peptide bond to amino acid residue 190 shown in SEQ ID NO:2 so that amino acid residues 1-133 and 190-505 shown in SEQ ID NO:2 are contiguously present within the polypeptide.

19. The isolated polypeptide of claim 17 wherein the isolated polypeptide comprises amino acid residue 133 shown in SEQ ID NO:8 attached via a peptide bond to amino acid residue 190 shown in SEQ ID No:8 so that amino acid residues 1-133 and 190-505 shown in SEQ ID No:8 are contiguously present within the polypeptide.

20. The isolated polypeptide of claim 1 further comprising a heterologous amino acid sequence.

21. The isolated polypeptide of claim 11 further comprising a heterologous amino acid sequence.

22. An isolated polypeptide comprising the amino acid sequence shown in SEQ ID NO:8.

23. An isolated polypeptide comprising an amino acid sequence encoded by the nucleic acid insert of the clone contained in ATCC Deposit No. 97222.

24. An isolated polypeptide comprising an amino acid sequence encoded by the nucleic acid insert of the clone contained in ATCC Deposit No. 97221.

25. An isolated polypeptide comprising an amino acid sequence encoded by the nucleic acid insert of the clone contained in ATCC Deposit No. 69874.

26. An isolated polypeptide comprising amino acid residues 1-133 shown in SEQ ID NO:8.

27. An isolated polypeptide comprising amino acid residues 190-506 shown in SEQ ID NO:8.

28. An isolated polypeptide comprising amino acid residues 1-133 and 190-506 shown in SEQ ID NO:8.

29. The isolated polypeptide comprising amino acid residue 133 shown in SEQ ID NO:8 attached via a peptide bond to amino acid residue 190 shown in SEQ ID NO:2 so that amino acid residues 1-133 and 190-505 shown in SEQ ID NO:8 are contiguously present within the polypeptide.

Referenced Cited
Other references
  • Friedman, J.M. et al., 1991, "Molecular Mapping of Obesity Genes", Mamm. Genome 1:130-144. Bray,G.A., 1992, "Genetic, Hypothalamic and Endocrine Features of Clinical and Experimental Obesity", Prog. Brain Res. 93:333-341. Friedman, J.M. and Leibel, R.L., 1992, "Tackling a Weighty Problem", Cell 69:217-220. Coleman, D.L. and Eicher, E.M., 1990, "Fat (fat) and Tubby (tub): Two Autosomal Recessive Mutations Causing Obesity Syndromes in the Mouse", J. Hered. 81:424-427. Jones, J.M. et al., 1992, "Localization of Insulin-2 (Ins-2) and the Obesity Mutant Tubby (tub) to Distinct Regions of Mouse Chromosome 7", Genomics 14:197-199. Warden, C.H. et al., 1993, "Coincidence of Genetic Loci for Plasma Cholesterol Levels and Obesity in a Multifactorial Mouse Model", J. Clin. Invest. 92:773-779. Nishina, P.M. et al., 1994, "Characterization of Plasma Lipids in Genetically Obese Mice: The Mutants Obese, Diabetes, Fat, Tubby, and Lethal Yellow", Metabolism 43:549-553. Nishina, P.M. et al., 1994, "Atherosclerosis in Genetically Obese Mice: The Mutants Obese, Diabetes, Fat, Tubby, and Lethal Yellow", Metabolism 43:554-558. Seldin, M.F. et al., 1994, "Glycogen Synthase: A Putative Locus for Diet-Induced Hyperglycemia", J. Clin. Invest. 94:269-276. West, D.B. et al., 1994, "Genetics of Dietary Obesity in AKR/J X SWR/J Mice: Segregation of the Trait and Identification of a Linked Locus on Chromosome 4", Mamm. Genome 5:546-552. Warden, C.H. et al., 1995, "Identification of Four Chromosomal Loci Determining Obesity in a Multifactorial Mouse Model", J. Clin. Invest. 95:1545-1552. Samuelson, L.C. et al., 1995, "Localization of the Murine Cholecystokinin A and B Receptor Genes", Mamm. Genome 6:242-246. Ohlemiller, K.K. et al., 1995, "Cochlear and Retinal Degeneration in the tubbyMouse", Neuroreport 6:845-849. Heckenlively, J.R. et al., 1995, "Mouse Model for Usher Syndrome: Linkage Mapping Suggests Homology to Usher Type I Reported at Human Chromosome 11p15", Proc. Natl. Acad. Sci. USA 92:11100-11104. Chung, W.K. et al., 1996, "Molecular Mapping of the Tubby (tub) Mutation on Mouse Chromosome 7", Genomics 32:210-217. Genbank Accession No. X69827 NCBI Entrez Record. Vambutas, V. and Wolgemuth, D.J., 1994, "Identification and Characterization of the Developmentally Regulated Pattern of Expression in the Testis of a Mouse Gene Exhibiting Similarity to the Family of Phosphodiesterases", Biochim. Biophys. Acta 1217:203-206. Genbank Accession No. Z48334 NCBI Entrez Record. Wilson, R. et al., 1994 "2.2 Mb of Contiguous Nucleotide Sequence from Chromosome III of C. elegans", Nature 368:32-38. Genbank Accession No. Z50688 NCBI Entrez Record. Genbank Accession No. H92408 NCBI Entrez Record. Bray, GA, 1989, "1989 McCollum Award Lecture. Genetic and Hypothalamic Mechanisms for Obesity-Finding the Needle in the Haystack" Am. J. Clin. Nur. 50:891-902. Borjeson, M., 1976, "The Aetiology of Obesity in Children", Acta. Paediatr. Scand. 65:279:287. Chen, H. et al., "Evidence that the Diabetes Gene Encodes the leptin Receptor: identification of a Mutation in the Leptin Receptor Gene in db/db Mice", Cell 84:491-495. Coleman, D.L., 1978, "Obese and Diabetes: Two Mutant Genes causing Diabetes-Obesity Syndromes in Mice", Diabetologia 14:141-148. Grundy and Barnett, 1990, Dis. Mon. 36:641-731. Heckenlively, 1988, in Retinitis Pigmentosa, Heckenlively, ed., Lippincott, Philadelphia, pp. 221-235. Herberg and Coleman, 1977, "Laboratory Animals Exhibiting Obesity and Diabetes Syndromes", Metabolism 26:59-59. Kleyn, P. et al., 1996, "Identification and Characterization of the Mouse Obesity Gens tubby: A Member of a Novel Gene Family", Cell 85:281-290. Knoll, J.H. et al., 1993, Am. J. Med. Genet. 46:2-6. Marshall, E., 1995, "Gene Therapy's Growing Pains", Science 269:1050-1055. Michaud, E. et al., 1994, "Differential Expression of a New Dominant Agouti Allele (A.sup.ispy) is Correlated with Methylation State and is Influenced by Parental Lineage", Genes Devel. 8:1463-1472. Moll, et al., 1991, "The Genetic and Environmental Sources of Body Mass Index Variability: The Muscatime Ponderosity Family Study", Am. J. Hum. Gen. 49:1243-1255. Naggert, J. et al., 1995, "Hyperproinsulinaemia in Obese fat/fat Mice Associated with a Carboxypeptidase E Mutation which Reduces Enzyme Activity", Nature Genetics 10:135-141. Noben-Trauth, K. et al., 1996, "A Candidate Gene for the Mouse Mutation Tubby", Nature 380:534-538. Leibel, R. et al., 1990, in "Genetic Variation and Nutrition in Obesity", Simopoulos AP, Childs B (eds): Genetic Variation and Nutrition. World Rev. Nutr. Diab. basel, Karger, Switzerland, Vol.63, pp. 90-101. Stunkard, 1990, "The Body-Mass Index of Twins Who Have Been Reared Apart", N. Engl. J. Med. 322:1483-1487. Tartaglia, L.A. et al., 1995, "Identification and Expression Cloning of a Leptin Receptor", Cell 83:1263-1271. Zhang, Y et al., 1994, "Positional Cloning of the Mouse Obese Gene and its Human Homologue", Nature 372:425-432.
Patent History
Patent number: 5817762
Type: Grant
Filed: Mar 28, 1997
Date of Patent: Oct 6, 1998
Assignee: Millennium Pharmaceuticals, Inc. (Cambridge, MA)
Inventors: Patrick W. Kleyn (Cambridge, MA), Karen J. Moore (Maynard, MA)
Primary Examiner: Johnny F. Railey II
Law Firm: Pennie & Edmonds
Application Number: 8/829,553
Classifications
Current U.S. Class: Proteins, I.e., More Than 100 Amino Acid Residues (530/350); 536/235
International Classification: C07K 1447; C12N 1511; C12N 1512;